ArticleBMC complementary medicine and therapies2023

Preclinical evaluation of antimalarial activity of CPF-1 formulation as an alternative choice for the treatment of malaria.

Prapaporn Chaniad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.